ANNXAnnexon, Inc.
- Market cap
- $710.92M
- as of 2026-10-23
- Latest close
- $3.75
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-12-28
Dashed line = amended filing (Form 4/A)
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Love DouglasPRESIDENT AND CEO | Sep 24 | Sep 25 | P | 26,065 | $3.83 | Purchase +$99,829 | 390,476 | No | Form 4 |
| Blumenkranz Mark S. | Aug 10 | Aug 12 | A · derivative | 175,000 | $5.39 | $943,250 | 175,000 | No | Form 4 |
| Satter Muneer A | Jun 11 | Jun 15 | A · derivative | 65,000 | $4.70 | $305,500 | 65,000 | No | Form 4 |
| Jones William A Jr | Jun 11 | Jun 15 | A · derivative | 65,000 | $4.70 | $305,500 | 65,000 | No | Form 4 |
| Waddill William D. | Jun 11 | Jun 15 | A · derivative | 65,000 | $4.70 | $305,500 | 65,000 | No | Form 4 |
| Choi Jung | Jun 11 | Jun 15 | A · derivative | 65,000 | $4.70 | $305,500 | 65,000 | No | Form 4 |
| Yednock TedEVP & CHIEF INNOVATION OFFICER | Jun 11 | Jun 15 | M | 30,646 | $1.85 | $56,695 | 184,807 | Yes | Form 4 |
| Yednock TedEVP & CHIEF INNOVATION OFFICER | Jun 11 | Jun 15 | M · derivative | 30,646 | $1.85 | $56,695 | not reported | Yes | Form 4 |
| Carson William H. | Jun 11 | Jun 15 | A · derivative | 65,000 | $4.70 | $305,500 | 65,000 | No | Form 4 |
| Cockroft Bettina M. | Jun 11 | Jun 15 | A · derivative | 65,000 | $4.70 | $305,500 | 65,000 | No | Form 4 |
| Satter Muneer A | May 28 | May 29 | P | 613,497 | $5.41 | Purchase +$3,319,019 | 10,342,134 | No | Form 4 |
| Carson William H. | May 11 | May 13 | P | 8,000 | $5.78 | Purchase +$46,240 | 78,405 | Yes | Form 4 |
| Carson William H. | Apr 10 | Apr 14 | P | 8,000 | $6.20 | Purchase +$49,600 | 70,405 | Yes | Form 4 |
| Carson William H. | Mar 10 | Mar 12 | P | 8,000 | $5.67 | Purchase +$45,360 | 62,405 | Yes | Form 4 |
| Lew JenniferEVP & CHIEF FINANCIAL OFFICER | Mar 2 | Mar 4 | S | 5,565 | $5.42 | Sale −$30,162 | 170,700 | No | Form 4 |
| Dananberg JamieCHIEF MEDICAL OFFICER | Mar 2 | Mar 4 | S | 5,820 | $5.43 | Sale −$31,603 | 123,582 | No | Form 4 |
| Overdorf MichaelEVP & CHIEF BUSINESS OFFICER | Mar 2 | Mar 4 | S | 4,339 | $5.42 | Sale −$23,517 | 182,625 | No | Form 4 |
| Yednock TedEVP & CHIEF INNOVATION OFFICER | Mar 2 | Mar 4 | S | 5,566 | $5.42 | Sale −$30,168 | 154,161 | No | Form 4 |
| Artis Dean RichardEVP & CHIEF SCIENTIFIC OFFICER | Mar 2 | Mar 4 | S | 5,894 | $5.43 | Sale −$32,004 | 180,093 | No | Form 4 |
| Lew JenniferEVP & CHIEF FINANCIAL OFFICER | Feb 19 | Feb 23 | A | 62,500 | $0.00 | $0 | 176,265 | No | Form 4 |
| Lew JenniferEVP & CHIEF FINANCIAL OFFICER | Feb 19 | Feb 23 | A · derivative | 250,000 | $5.10 | $1,275,000 | 250,000 | No | Form 4 |
| Dananberg JamieCHIEF MEDICAL OFFICER | Feb 19 | Feb 23 | A | 56,250 | $0.00 | $0 | 129,402 | No | Form 4 |
| Dananberg JamieCHIEF MEDICAL OFFICER | Feb 19 | Feb 23 | A · derivative | 225,000 | $5.10 | $1,147,500 | 225,000 | No | Form 4 |
| Love DouglasPRESIDENT AND CEO | Feb 19 | Feb 23 | A · derivative | 1,250,000 | $5.10 | $6,375,000 | 1,250,000 | No | Form 4 |
| Overdorf MichaelEVP & CHIEF BUSINESS OFFICER | Feb 19 | Feb 23 | A | 62,500 | $0.00 | $0 | 186,964 | No | Form 4 |
| Overdorf MichaelEVP & CHIEF BUSINESS OFFICER | Feb 19 | Feb 23 | A · derivative | 250,000 | $5.10 | $1,275,000 | 250,000 | No | Form 4 |
| Yednock TedEVP & CHIEF INNOVATION OFFICER | Feb 19 | Feb 23 | A | 62,500 | $0.00 | $0 | 159,727 | No | Form 4 |
| Yednock TedEVP & CHIEF INNOVATION OFFICER | Feb 19 | Feb 23 | A · derivative | 250,000 | $5.10 | $1,275,000 | 250,000 | No | Form 4 |
| Artis Dean RichardEVP & CHIEF SCIENTIFIC OFFICER | Feb 19 | Feb 23 | A | 62,500 | $0.00 | $0 | 185,987 | No | Form 4 |
| Artis Dean RichardEVP & CHIEF SCIENTIFIC OFFICER | Feb 19 | Feb 23 | A · derivative | 250,000 | $5.10 | $1,275,000 | 250,000 | No | Form 4 |
| Lew JenniferEVP & CHIEF FINANCIAL OFFICER | Feb 18 | Feb 20 | S | 7,851 | $5.11 | Sale −$40,119 | 113,765 | No | Form 4 |
| Dananberg JamieCHIEF MEDICAL OFFICER | Feb 18 | Feb 20 | S | 5,290 | $5.10 | Sale −$26,979 | 73,152 | No | Form 4 |
| Overdorf MichaelEVP & CHIEF BUSINESS OFFICER | Feb 18 | Feb 20 | S | 6,225 | $5.10 | Sale −$31,748 | 124,464 | No | Form 4 |
| Yednock TedEVP & CHIEF INNOVATION OFFICER | Feb 18 | Feb 20 | S | 7,857 | $5.11 | Sale −$40,149 | 97,227 | No | Form 4 |
| Artis Dean RichardEVP & CHIEF SCIENTIFIC OFFICER | Feb 18 | Feb 20 | S | 5,290 | $5.10 | Sale −$26,979 | 123,487 | No | Form 4 |
| Carson William H. | Dec 30, 2025 | Jan 2 | P | 4,115 | $5.02 | Purchase +$20,657 | 54,405 | Yes | Form 4 |
| Choi Jung | Dec 1, 2025 | Dec 3, 2025 | P | 33,000 | $4.19 | Purchase +$138,270 | 33,000 | No | Form 4 |
| Carson William H. | Dec 1, 2025 | Dec 3, 2025 | P | 4,115 | $4.47 | Purchase +$18,394 | 50,290 | Yes | Form 4 |
| Satter Muneer A | Nov 21, 2025 | Nov 21, 2025 | P | 422,613 | $4.28 | Purchase +$1,808,784 | 9,728,637 | No | Form 4 |
| Satter Muneer A | Nov 20, 2025 | Nov 21, 2025 | P | 400,000 | $4.48 | Purchase +$1,792,000 | 9,306,024 | No | Form 4 |
| Satter Muneer A | Nov 19, 2025 | Nov 19, 2025 | P | 500,000 | $3.94 | Purchase +$1,970,000 | 8,906,024 | No | Form 4 |
| Satter Muneer A | Nov 18, 2025 | Nov 19, 2025 | P | 500,000 | $3.18 | Purchase +$1,590,000 | 8,406,024 | No | Form 4 |
| Satter Muneer A | Nov 17, 2025 | Nov 19, 2025 | P | 500,000 | $2.99 | Purchase +$1,495,000 | 7,906,024 | No | Form 4 |
| Carson William H. | Oct 30, 2025 | Oct 31, 2025 | P | 4,115 | $3.17 | Purchase +$13,045 | 46,175 | Yes | Form 4 |
| Carson William H. | Sep 30, 2025 | Oct 2, 2025 | P | 4,115 | $3.05 | Purchase +$12,551 | 42,060 | Yes | Form 4 |
| Carson William H. | Sep 2, 2025 | Sep 4, 2025 | P | 4,115 | $2.09 | Purchase +$8,600 | 37,945 | Yes | Form 4 |
| Carson William H. | Jul 30, 2025 | Aug 1, 2025 | P | 4,115 | $2.43 | Purchase +$9,999 | 33,830 | Yes | Form 4 |
| Overdorf MichaelEVP & CHIEF BUSINESS OFFICER | Jul 14, 2025 | Jul 16, 2025 | S | 853 | $2.61 | Sale −$2,226 | 130,689 | No | Form 4 |
| Lew JenniferEVP & CHIEF FINANCIAL OFFICER | Jul 14, 2025 | Jul 16, 2025 | S | 1,117 | $2.58 | Sale −$2,882 | 121,616 | No | Form 4 |
| Yednock TedEVP & CHIEF INNOVATION OFFICER | Jul 14, 2025 | Jul 16, 2025 | S | 1,116 | $2.58 | Sale −$2,879 | 105,084 | No | Form 4 |
| Carson William H. | Jun 30, 2025 | Jul 1, 2025 | P | 4,115 | $2.46 | Purchase +$10,123 | 29,715 | Yes | Form 4 |
| Cockroft Bettina M. | Jun 5, 2025 | Jun 9, 2025 | A · derivative | 55,000 | $2.55 | $140,250 | 55,000 | No | Form 4 |
| Jones William A Jr | Jun 5, 2025 | Jun 9, 2025 | A · derivative | 55,000 | $2.55 | $140,250 | 55,000 | No | Form 4 |
| Choi Jung | Jun 5, 2025 | Jun 9, 2025 | A · derivative | 55,000 | $2.55 | $140,250 | 55,000 | No | Form 4 |
| Carson William H. | Jun 5, 2025 | Jun 9, 2025 | A · derivative | 55,000 | $2.55 | $140,250 | 55,000 | No | Form 4 |
| Waddill William D. | Jun 5, 2025 | Jun 9, 2025 | A · derivative | 55,000 | $2.55 | $140,250 | 55,000 | No | Form 4 |
| Satter Muneer A | Jun 5, 2025 | Jun 9, 2025 | A · derivative | 55,000 | $2.55 | $140,250 | 55,000 | No | Form 4 |
| Wiggans Thomas G | Jun 5, 2025 | Jun 9, 2025 | A · derivative | 55,000 | $2.55 | $140,250 | 55,000 | No | Form 4 |
| Overdorf MichaelEVP & CHIEF BUSINESS OFFICER | Feb 27, 2025 | Mar 3, 2025 | A · derivative | 272,575 | $2.50 | $681,438 | 272,575 | No | Form 4 |
| Yednock TedEVP & CHIEF INNOVATION OFFICER | Feb 27, 2025 | Mar 3, 2025 | A · derivative | 272,575 | $2.50 | $681,438 | 272,575 | No | Form 4 |
| Love DouglasPRESIDENT AND CEO | Feb 27, 2025 | Mar 3, 2025 | A · derivative | 1,300,000 | $2.50 | $3,250,000 | 1,300,000 | No | Form 4 |
| Lew JenniferEVP & CHIEF FINANCIAL OFFICER | Feb 27, 2025 | Mar 3, 2025 | A · derivative | 272,575 | $2.50 | $681,438 | 272,575 | No | Form 4 |
| Dananberg JamieCHIEF MEDICAL OFFICER | Feb 27, 2025 | Mar 3, 2025 | A · derivative | 228,225 | $2.50 | $570,563 | 228,225 | No | Form 4 |
| Artis Dean RichardEVP & CHIEF SCIENTIFIC OFFICER | Feb 27, 2025 | Mar 3, 2025 | A · derivative | 272,575 | $2.50 | $681,438 | 272,575 | No | Form 4 |
| Overdorf MichaelEVP & CHIEF BUSINESS OFFICER | Feb 27, 2024 | Mar 3, 2025 | A | 44,963 | $0.00 | $0 | 131,542 | No | Form 4 |
| Yednock TedEVP & CHIEF INNOVATION OFFICER | Feb 27, 2024 | Mar 3, 2025 | A | 44,963 | $0.00 | $0 | 106,200 | No | Form 4 |
| Lew JenniferEVP & CHIEF FINANCIAL OFFICER | Feb 27, 2024 | Mar 3, 2025 | A | 44,963 | $0.00 | $0 | 122,733 | No | Form 4 |
| Dananberg JamieCHIEF MEDICAL OFFICER | Feb 27, 2024 | Mar 3, 2025 | A | 44,963 | $0.00 | $0 | 78,442 | No | Form 4 |
| Artis Dean RichardEVP & CHIEF SCIENTIFIC OFFICER | Feb 27, 2024 | Mar 3, 2025 | A | 44,963 | $0.00 | $0 | 128,777 | No | Form 4 |
| Lew JenniferEVP & CHIEF FINANCIAL OFFICER | Feb 18, 2025 | Feb 20, 2025 | S | 6,912 | $2.92 | Sale −$20,183 | 77,770 | No | Form 4 |
| Overdorf MichaelEVP & CHIEF BUSINESS OFFICER | Feb 18, 2025 | Feb 20, 2025 | S | 6,618 | $2.95 | Sale −$19,523 | 86,579 | No | Form 4 |
| Yednock TedEVP & CHIEF INNOVATION OFFICER | Feb 18, 2025 | Feb 20, 2025 | S | 8,345 | $2.91 | Sale −$24,284 | 61,237 | No | Form 4 |
| Artis Dean RichardEVP & CHIEF SCIENTIFIC OFFICER | Feb 18, 2025 | Feb 20, 2025 | S | 5,515 | $2.97 | Sale −$16,380 | 83,814 | No | Form 4 |
| Dananberg JamieCHIEF MEDICAL OFFICER | Feb 18, 2025 | Feb 20, 2025 | S | 5,521 | $2.96 | Sale −$16,342 | 33,479 | No | Form 4 |
| Overdorf MichaelEVP & CHIEF BUSINESS OFFICER | Feb 13, 2025 | Feb 18, 2025 | S | 1,425 | $2.99 | Sale −$4,261 | 93,197 | No | Form 4 |
| Yednock TedEVP & CHIEF INNOVATION OFFICER | Feb 13, 2025 | Feb 18, 2025 | S | 1,783 | $2.99 | Sale −$5,331 | 69,582 | No | Form 4 |
| Lew JenniferEVP & CHIEF FINANCIAL OFFICER | Feb 13, 2025 | Feb 18, 2025 | S | 1,786 | $2.98 | Sale −$5,322 | 84,682 | No | Form 4 |
| Love DouglasPRESIDENT AND CEO | Feb 13, 2025 | Feb 18, 2025 | S | 5,021 | $2.95 | Sale −$14,812 | 351,554 | No | Form 4 |
| Jones William A Jr | Jan 9, 2025 | Jan 10, 2025 | A · derivative | 88,000 | $4.83 | $425,040 | 88,000 | No | Form 4 |
| Love DouglasPRESIDENT AND CEO | Jan 6, 2025 | Jan 8, 2025 | M | 37,994 | $1.41 | $53,572 | 356,575 | No | Form 4 |
| Love DouglasPRESIDENT AND CEO | Jan 6, 2025 | Jan 8, 2025 | M · derivative | 37,994 | $1.41 | $53,572 | not reported | No | Form 4 |
| Carson William H. | Dec 2, 2024 | Dec 4, 2024 | P | 3,200 | $5.33 | Purchase +$17,056 | 25,600 | Yes | Form 4 |
| Love DouglasPRESIDENT AND CEO | Oct 30, 2024 | Nov 1, 2024 | M | 78,399 | $1.85 | $145,038 | 274,520 | No | Form 4 |
| Love DouglasPRESIDENT AND CEO | Oct 30, 2024 | Nov 1, 2024 | M | 36,050 | $1.85 | $66,693 | 310,570 | No | Form 4 |
| Love DouglasPRESIDENT AND CEO | Oct 30, 2024 | Nov 1, 2024 | M · derivative | 78,399 | $1.85 | $145,038 | not reported | No | Form 4 |
| Love DouglasPRESIDENT AND CEO | Oct 30, 2024 | Nov 1, 2024 | M · derivative | 36,050 | $1.85 | $66,693 | not reported | No | Form 4 |
| Yednock TedEVP & CHIEF INNOVATION OFFICER | Oct 15, 2024 | Oct 17, 2024 | M | 5,408 | $1.85 | $10,005 | 76,773 | Yes | Form 4 |
| Yednock TedEVP & CHIEF INNOVATION OFFICER | Oct 15, 2024 | Oct 17, 2024 | S | 5,408 | $7.41 | Sale −$40,073 | 71,365 | Yes | Form 4 |
| Yednock TedEVP & CHIEF INNOVATION OFFICER | Oct 15, 2024 | Oct 17, 2024 | M · derivative | 5,408 | $1.85 | $10,005 | 30,646 | Yes | Form 4 |
| Carson William H. | Oct 1, 2024 | Oct 2, 2024 | P | 3,200 | $5.97 | Purchase +$19,104 | 22,400 | Yes | Form 4 |
| Yednock TedEVP & CHIEF INNOVATION OFFICER | Sep 19, 2024 | Sep 20, 2024 | S | 4,500 | $7.10 | Sale −$31,950 | not reported | Yes | Form 4 |
| Yednock TedEVP & CHIEF INNOVATION OFFICER | Sep 12, 2024 | Sep 16, 2024 | S | 5,500 | $6.16 | Sale −$33,880 | 4,500 | Yes | Form 4 |
| Yednock TedEVP & CHIEF INNOVATION OFFICER | Sep 5, 2024 | Sep 6, 2024 | S | 5,500 | $5.64 | Sale −$31,020 | 10,000 | Yes | Form 4 |
| Carson William H. | Sep 3, 2024 | Sep 4, 2024 | P | 3,200 | $5.48 | Purchase +$17,536 | 19,200 | Yes | Form 4 |
| Yednock TedEVP & CHIEF INNOVATION OFFICER | Aug 29, 2024 | Aug 30, 2024 | S | 5,500 | $5.95 | Sale −$32,725 | 15,500 | Yes | Form 4 |
| Carson William H. | Aug 1, 2024 | Aug 5, 2024 | P | 3,200 | $6.24 | Purchase +$19,968 | 16,000 | Yes | Form 4 |
| Yednock TedEVP & CHIEF INNOVATION OFFICER | Jul 15, 2024 | Jul 17, 2024 | S | 1,106 | $6.02 | Sale −$6,658 | 71,365 | No | Form 4 |
| Lew JenniferEVP & CHIEF FINANCIAL OFFICER | Jul 15, 2024 | Jul 17, 2024 | S | 1,104 | $6.03 | Sale −$6,657 | 86,468 | No | Form 4 |
| Overdorf MichaelEVP & CHIEF BUSINESS OFFICER | Jul 15, 2024 | Jul 17, 2024 | S | 784 | $6.02 | Sale −$4,720 | 94,622 | No | Form 4 |
| Carson William H. | Jul 1, 2024 | Jul 2, 2024 | P | 3,200 | $5.00 | Purchase +$16,000 | 12,800 | Yes | Form 4 |
| Cockroft Bettina M. | Jun 5, 2024 | Jun 7, 2024 | A · derivative | 44,000 | $6.79 | $298,760 | 44,000 | No | Form 4 |
| Carson William H. | Jun 5, 2024 | Jun 7, 2024 | A · derivative | 44,000 | $6.79 | $298,760 | 44,000 | No | Form 4 |
| Waddill William D. | Jun 5, 2024 | Jun 7, 2024 | A · derivative | 44,000 | $6.79 | $298,760 | 44,000 | No | Form 4 |
| Choi Jung | Jun 5, 2024 | Jun 7, 2024 | A · derivative | 44,000 | $6.79 | $298,760 | 44,000 | No | Form 4 |
| Satter Muneer A | Jun 5, 2024 | Jun 7, 2024 | A · derivative | 44,000 | $6.79 | $298,760 | 44,000 | No | Form 4 |
| Wiggans Thomas G | Jun 5, 2024 | Jun 7, 2024 | A · derivative | 44,000 | $6.79 | $298,760 | 44,000 | No | Form 4 |
| Carson William H. | Jun 3, 2024 | Jun 5, 2024 | P | 3,200 | $4.83 | Purchase +$15,456 | 9,600 | Yes | Form 4 |
| Carson William H. | May 1, 2024 | May 3, 2024 | P | 3,200 | $4.68 | Purchase +$14,976 | 6,400 | Yes | Form 4 |
| Carson William H. | Apr 8, 2024 | Apr 10, 2024 | P | 3,200 | $6.07 | Purchase +$19,424 | 3,200 | Yes | Form 4 |
| Lew JenniferEVP & CHIEF FINANCIAL OFFICER | Feb 20, 2024 | Feb 21, 2024 | S | 2,593 | $5.53 | Sale −$14,339 | 82,058 | No | Form 4 |
| Overdorf MichaelEVP & CHIEF BUSINESS OFFICER | Feb 20, 2024 | Feb 21, 2024 | S | 1,951 | $5.48 | Sale −$10,691 | 85,641 | No | Form 4 |
| Yednock TedEVP & CHIEF INNOVATION OFFICER | Feb 20, 2024 | Feb 21, 2024 | S | 2,604 | $5.51 | Sale −$14,348 | 72,471 | No | Form 4 |
| Lew JenniferEVP & CHIEF FINANCIAL OFFICER | Feb 16, 2024 | Feb 21, 2024 | A | 39,000 | $0.00 | $0 | 84,651 | No | Form 4 |
| Lew JenniferEVP & CHIEF FINANCIAL OFFICER | Feb 16, 2024 | Feb 21, 2024 | A · derivative | 160,000 | $5.13 | $820,800 | 160,000 | No | Form 4 |
| Overdorf MichaelEVP & CHIEF BUSINESS OFFICER | Feb 16, 2024 | Feb 21, 2024 | A | 39,000 | $0.00 | $0 | 87,592 | No | Form 4 |
| Overdorf MichaelEVP & CHIEF BUSINESS OFFICER | Feb 16, 2024 | Feb 21, 2024 | A · derivative | 160,000 | $5.13 | $820,800 | 160,000 | No | Form 4 |
| Yednock TedEVP & CHIEF INNOVATION OFFICER | Feb 16, 2024 | Feb 21, 2024 | A | 39,000 | $0.00 | $0 | 75,075 | No | Form 4 |
| Yednock TedEVP & CHIEF INNOVATION OFFICER | Feb 16, 2024 | Feb 21, 2024 | A · derivative | 160,000 | $5.13 | $820,800 | 160,000 | No | Form 4 |
| Artis Dean RichardEVP & CHIEF SCIENTIFIC OFFICER | Feb 16, 2024 | Feb 21, 2024 | A | 39,000 | $0.00 | $0 | 89,329 | No | Form 4 |
| Artis Dean RichardEVP & CHIEF SCIENTIFIC OFFICER | Feb 16, 2024 | Feb 21, 2024 | A · derivative | 160,000 | $5.13 | $820,800 | 160,000 | No | Form 4 |
| Dananberg JamieCHIEF MEDICAL OFFICER | Feb 16, 2024 | Feb 21, 2024 | A | 39,000 | $0.00 | $0 | 39,000 | No | Form 4 |
| Dananberg JamieCHIEF MEDICAL OFFICER | Feb 16, 2024 | Feb 21, 2024 | A · derivative | 160,000 | $5.13 | $820,800 | 160,000 | No | Form 4 |
| Love DouglasPRESIDENT AND CEO | Feb 16, 2024 | Feb 21, 2024 | A · derivative | 656,200 | $5.13 | $3,366,306 | 656,200 | No | Form 4 |
| Yednock TedEVP & CHIEF INNOVATION OFFICER | Feb 12, 2024 | Feb 14, 2024 | S | 1,810 | $5.54 | Sale −$10,027 | 36,075 | No | Form 4 |
| Lew JenniferEVP & CHIEF FINANCIAL OFFICER | Feb 12, 2024 | Feb 14, 2024 | S | 1,809 | $5.54 | Sale −$10,022 | 45,651 | No | Form 4 |
| Love DouglasPRESIDENT AND CEO | Feb 12, 2024 | Feb 14, 2024 | S | 5,782 | $5.54 | Sale −$32,032 | 196,121 | No | Form 4 |
| Overdorf MichaelEVP & CHIEF BUSINESS OFFICER | Feb 12, 2024 | Feb 14, 2024 | S | 1,349 | $5.53 | Sale −$7,460 | 48,592 | No | Form 4 |
| Yednock TedEVP & Chief Innovation Officer | Dec 27, 2023 | Jan 23, 20244/A | M | 10,615 | $1.41 | $14,967 | 48,500 | Yes | Form 4/A |
| Yednock TedEVP & Chief Innovation Officer | Dec 27, 2023 | Jan 23, 20244/A | M | 10,385 | $1.85 | $19,212 | 58,885 | Yes | Form 4/A |
| Yednock TedEVP & Chief Innovation Officer | Dec 27, 2023 | Jan 23, 20244/A | S | 21,000 | $4.52 | Sale −$94,920 | 37,885 | Yes | Form 4/A |
| Lew JenniferEVP & Chief Financial Officer | Jul 11, 2023 | Jan 23, 2024 | S | 1,057 | $3.84 | Sale −$4,059 | 47,460 | No | Form 4 |
| Overdorf MichaelEVP & Chief Business Officer | Jul 11, 2023 | Jan 23, 2024 | S | 978 | $3.84 | Sale −$3,756 | 45,802 | No | Form 4 |
| Yednock TedEVP & Chief Innovation Officer | Jul 11, 2023 | Jan 23, 20244/A | S | 1,057 | $3.84 | Sale −$4,059 | 37,885 | Yes | Form 4/A |
| Yednock TedEVP & Chief Innovation Officer | Dec 27, 2023 | Dec 29, 2023 | M | 10,615 | $1.41 | $14,967 | 10,615 | Yes | Form 4 |
| Yednock TedEVP & Chief Innovation Officer | Dec 27, 2023 | Dec 29, 2023 | M | 10,385 | $1.85 | $19,212 | 21,000 | Yes | Form 4 |
| Yednock TedEVP & Chief Innovation Officer | Dec 27, 2023 | Dec 29, 2023 | S | 21,000 | $4.52 | Sale −$94,920 | not reported | Yes | Form 4 |
| Yednock TedEVP & Chief Innovation Officer | Dec 27, 2023 | Dec 29, 2023 | M · derivative | 10,615 | $1.41 | $14,967 | not reported | Yes | Form 4 |
| Yednock TedEVP & Chief Innovation Officer | Dec 27, 2023 | Dec 29, 2023 | M · derivative | 10,385 | $1.85 | $19,212 | 36,000 | Yes | Form 4 |
| Satter Muneer A | Dec 26, 2023 | Dec 28, 2023 | P | 350,000 | $2.88 | Purchase +$1,008,000 | 7,406,024 | No | Form 4 |